{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:47:55Z","timestamp":1773334075170,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.trim.2026.102358","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:11:51Z","timestamp":1770225111000},"page":"102358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Gamma delta T cell reconstitution in Acute Lymphoblastic Leukemia patients post allogeneic HSCT predicts clinical outcome and overall survival"],"prefix":"10.1016","volume":"95","author":[{"given":"Gauri","family":"Mirji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Punatar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navin","family":"Khattry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubhada","family":"Chiplunkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.trim.2026.102358_bb0005","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2026.102358_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/578741","article-title":"Alpha\/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors","volume":"2014","author":"Radestad","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"8","key":"10.1016\/j.trim.2026.102358_bb0015","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1080\/10428194.2016.1265113","article-title":"Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant","volume":"58","author":"Goldberg","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"12","key":"10.1016\/j.trim.2026.102358_bb0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/0032472031000141295","article-title":"Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effect","volume":"1","author":"Lamb","year":"1999","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbmt.2014.09.027","article-title":"Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia","volume":"21","author":"Perko","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"10","key":"10.1016\/j.trim.2026.102358_bb0035","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood-2017-08-752162","article-title":"The potential role of gammadelta T cells after allogeneic HCT for leukemia","volume":"131","author":"Handgretinger","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/cmi.2012.43","article-title":"Gammadelta-T cells: an unpolished sword in human anti-infection immunity","volume":"10","author":"Zheng","year":"2013","journal-title":"Cell. Mol. Immunol."},{"issue":"12","key":"10.1016\/j.trim.2026.102358_bb0045","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2010-01-255166","article-title":"The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation","volume":"116","author":"Knight","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.trim.2026.102358_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1078","article-title":"The complex existence of gammadelta T cells following transplantation: the good, the bad and the simply confusing","volume":"8","author":"Sullivan","year":"2019","journal-title":"Clin Transl Immunology"},{"issue":"6","key":"10.1016\/j.trim.2026.102358_bb0055","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/leu.2012.374","article-title":"gammadeltaT cells elicited by CMV reactivation after Allo-SCT cross-recognize CMV and leukemia","volume":"27","author":"Scheper","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.trim.2026.102358_bb0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ni.3686","article-title":"Human gammadelta T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection","volume":"18","author":"Ravens","year":"2017","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.trim.2026.102358_bb0065","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/s41409-019-0462-z","article-title":"T-cell frequencies of CD8(+) gammadelta and CD27(+) gammadelta cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation","volume":"54","author":"Gaballa","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.trim.2026.102358_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081757","article-title":"Engineering the bridge between innate and adaptive immunity for Cancer immunotherapy: focus on gammadelta T and NK cells","volume":"9","author":"Morandi","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.trim.2026.102358_bb0075","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2018.02.023","article-title":"Early reconstitution of NK and gammadelta T cells and its implication for the Design of Post-Transplant Immunotherapy","volume":"24","author":"de Witte","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2026.102358_bb0080","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/leu.2013.378","article-title":"Hunting for clinical translation with innate-like immune cells and their receptors","volume":"28","author":"Scheper","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/v14010117","article-title":"The role of gammadelta T cells as a line of Defense in viral infections after allogeneic stem cell transplantation: opportunities and challenges","volume":"14","author":"Janssen","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.trim.2026.102358_bb0090","doi-asserted-by":"crossref","first-page":"1433785","DOI":"10.3389\/fimmu.2024.1433785","article-title":"Lower incidence of grade II-IV acute graft-versus-host-disease in pediatric patients recovering with high Vdelta2+ T cells after allogeneic stem cell transplantation with unmanipulated bone marrow grafts: a prospective single-center cohort study","volume":"15","author":"Muller","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.trim.2026.102358_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000613","article-title":"Virtual global transplant laboratory standard operating procedures for blood collection, PBMC isolation, and storage","volume":"2","author":"Higdon","year":"2016","journal-title":"Transplant Direct"},{"issue":"4","key":"10.1016\/j.trim.2026.102358_bb0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2026.102358_bb0105","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI45449","article-title":"Cytomegalovirus: pathogen, paradigm, and puzzle","volume":"121","author":"Boeckh","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"3","key":"10.1016\/j.trim.2026.102358_bb0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.trim.2026.102358_bb0120","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1182\/blood.V86.10.3987.bloodjournal86103987","article-title":"Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia","volume":"86","author":"Hessner","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.trim.2026.102358_bb0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2141.1988.tb07628.x","article-title":"Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect","volume":"69","author":"Apperley","year":"1988","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.trim.2026.102358_bb0130","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood.V98.12.3192","article-title":"The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Ho","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.trim.2026.102358_bb0135","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fimmu.2014.00622","article-title":"Plasticity of gammadelta T cells: impact on the anti-tumor response","volume":"5","author":"Lafont","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.179.1.323","article-title":"CDR3 length in antigen-specific immune receptors","volume":"179","author":"Rock","year":"1994","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.trim.2026.102358_bb0145","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/ni.3705","article-title":"gammadelta T cells get adaptive","volume":"18","author":"Silva-Santos","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/10428194.2019.1650174","article-title":"Immunophenotype and function define TCRgammadelta + T-ALL as a distinct subgroup from TCRalphabeta + T-ALL patients","volume":"61","author":"Mirji","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.trim.2026.102358_bb0155","article-title":"Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient","volume":"70","author":"Paccoud","year":"2022","journal-title":"Curr Res Transl Med"},{"issue":"5","key":"10.1016\/j.trim.2026.102358_bb0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/322843","article-title":"Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role","volume":"184","author":"Lafarge","year":"2001","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.trim.2026.102358_bb0165","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s00262-005-0094-6","article-title":"Characterization of the gammadelta T cell response to acute leukemia","volume":"55","author":"Meeh","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.trim.2026.102358_bb0170","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1182\/blood-2011-02-339135","article-title":"Differentiation of human peripheral blood Vdelta1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells","volume":"118","author":"Correia","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.trim.2026.102358_bb0175","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/14653249.2011.553595","article-title":"Human Vdelta1 gammadelta T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells","volume":"13","author":"Siegers","year":"2011","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.trim.2026.102358_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016700","article-title":"Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model","volume":"6","author":"Siegers","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.trim.2026.102358_bb0185","doi-asserted-by":"crossref","first-page":"14760","DOI":"10.1038\/ncomms14760","article-title":"Clonal selection in the human Vdelta1 T cell repertoire indicates gammadelta TCR-dependent adaptive immune surveillance","volume":"8","author":"Davey","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.trim.2026.102358_bb0190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/infdis\/jiaa400","article-title":"Characterization of a unique gammadelta T cell subset as a specific marker of CMV infection severity","volume":"223","author":"Kaminski","year":"2021","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.trim.2026.102358_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1171","article-title":"High-dose post-transplant cyclophosphamide impairs gammadelta T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graft","volume":"9","author":"Stocker","year":"2020","journal-title":"Clin Transl Immunology"},{"issue":"23","key":"10.1016\/j.trim.2026.102358_bb0200","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1182\/blood-2013-04-497628","article-title":"MEKing it easier to prevent GVHD","volume":"121","author":"Martin","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.trim.2026.102358_bb0205","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jcyt.2018.01.006","article-title":"Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells","volume":"20","author":"Muller","year":"2018","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.trim.2026.102358_bb0210","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ejh.12283","article-title":"Naive subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting","volume":"92","author":"Cherel","year":"2014","journal-title":"Eur. J. Haematol."},{"issue":"9","key":"10.1016\/j.trim.2026.102358_bb0215","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2005.08.136","article-title":"Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning","volume":"23","author":"Baron","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.trim.2026.102358_bb0220","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/JCO.2007.11.1641","article-title":"Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival","volume":"26","author":"Valcarcel","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/bmt.2016.182","article-title":"Clinical separation of cGvHD and GvL and better GvHD-free\/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML","volume":"52","author":"Zheng","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.trim.2026.102358_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/bmt.2015.195","article-title":"Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients","volume":"51","author":"Fiuza-Luces","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2026.102358_bb0235","first-page":"1","article-title":"The effect of GVHD on long-term outcomes after peripheral blood allogeneic stem cell transplantation from an HLA-identical sibling in adult acute lymphocytic Leukemia: a landmark analysis approach in competing risks","volume":"8","author":"Jalali","year":"2014","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"12","key":"10.1016\/j.trim.2026.102358_bb0240","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bbmt.2016.09.006","article-title":"Early natural killer cell reconstitution predicts overall survival in T cell-replete allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Minculescu","year":"2016","journal-title":"Biol. Blood Marrow Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742600016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742600016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:54:37Z","timestamp":1773291277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632742600016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"alternative-id":["S096632742600016X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102358","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gamma delta T cell reconstitution in Acute Lymphoblastic Leukemia patients post allogeneic HSCT predicts clinical outcome and overall survival","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102358"}}